# Implantation or Injectable Dosage Form New Animal Drugs; Hemoglobin Glutamer-200 (bovine)
> **Food and Drug Administration** · Final rule. · Published 2000-04-18 · Effective 2000-04-18 · 65 FR 20731
## Document
- **Document number:** 00-9576
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 65 FR 20731
- **CFR reference:** 21 CFR 522
- **Publication date:** 2000-04-18
- **Effective date:** 2000-04-18
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Biopure Corp. The supplemental NADA provides for flexible dosing for use of hemoglobin glutamer-200 (bovine) to treat anemia in dogs.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2000/04/18/00-9576/implantation-or-injectable-dosage-form-new-animal-drugs-hemoglobin-glutamer-200-bovine)
---
*AI Analytics · CC0 1.0*